1 September 2025 - From today, Australians with paediatric psoriasis, fibrodysplasia, asthma, cystic fibrosis and blood cancer now have access to new and expanded cheaper medicines under the PBS.
Adalimumab (Humira) will be listed for the treatment of chronic plaque psoriasis for paediatric patients.